Emgality 00002-2377-11
Generic: Galcanezumab-Gnlm
- Manufacturer
- Eli Lilly And Company
- Dosage Form
- Injection, Solution
- Route
- Subcutaneous
- Product Type
- Human Prescription Drug
- Marketing Start
- September 27, 2018
- Listing Expires
- December 31, 2026
- Application
- BLA761063
Need to source Emgality? Find it on a pharmacy-to-pharmacy marketplace at better prices.
✓ DSCSA Compliant. ✓ Verified Pharmacies Only.P2P pharmacy marketplace.
Active Ingredients
| Ingredient | Strength |
|---|---|
| Galcanezumab | 120 mg/mL |
Selected Package
00002-2377-11Selected1 SYRINGE in 1 CARTON (0002-2377-11) / 1 mL in 1 SYRINGE (0002-2377-01)